Last kr177.50 SEK
Change Today -0.50 / -0.28%
Volume 33.2K
VITR On Other Exchanges
Symbol
Exchange
Stockholm
OTC US
Frankfurt
As of 5:53 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

vitrolife ab (VITR) Snapshot

Open
kr177.00
Previous Close
kr178.00
Day High
kr178.50
Day Low
kr175.50
52 Week High
01/9/15 - kr185.00
52 Week Low
01/30/14 - kr84.00
Market Cap
3.9B
Average Volume 10 Days
28.4K
EPS TTM
kr4.84
Shares Outstanding
21.7M
EX-Date
05/6/14
P/E TM
36.7x
Dividend
kr1.00
Dividend Yield
0.56%
Current Stock Chart for VITROLIFE AB (VITR)

Related News

No related news articles were found.

vitrolife ab (VITR) Related Businessweek News

No Related Businessweek News Found

vitrolife ab (VITR) Details

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction worldwide. The company offers fertility products, such as nutrient solutions; paraffin oil; additional media for in vitro fertilisation (IVF) procedures; vitrification products; G-Series media products; various sterile disposable instruments, including needles and pipettes used in IVF treatment; embryo monitoring solutions; micromanipulation solutions; sperm processing solutions; slow freezing products; and labware products comprising plastic dishes and test tubes required in an IVF lab. It also provides cell therapy services to researchers and cell therapy companies. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1981 and is headquartered in Göteborg, Sweden.

250 Employees
Last Reported Date: 11/6/14
Founded in 1981

vitrolife ab (VITR) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: kr3.7M
Compensation as of Fiscal Year 2013.

vitrolife ab (VITR) Key Developments

Vitrolife AB (publ)(OM:VITR) dropped from OMX Nordic Small Cap Index

Vitrolife AB (publ) will be removed from OMX Nordic Small Cap Index.

Vitrolife AB Reports Group and Parent Earnings Results for the Third Quarter and Nine Months Ended September 2014

Vitrolife AB reported group and parent earnings results for the third quarter and nine months ended September 2014. For the quarter, the group reported net sales of SEK 125,145,000 against SEK 108,642,000 a year ago. Operating income was SEK 43,718,000 against SEK 23,086,000 a year ago. Net income attributable to parent company's shareholders was SEK 35,493,000 or SEK 1.79 per share against SEK 16,935,000 or SEK 0.85 per share a year ago. Return on equity was 28.1% against 14.4% a year ago. Cash flow from operating activities was SEK 54,511,000 against SEK 30,987,000 a year ago. EBITDA was SEK 49 million against SEK 31 million a year ago. Fluctuations in exchange rates had a positive effect of SEK 2 million on operating income. For the nine months, the group reported net sales of SEK 373,653,000 against SEK 329,236,000 a year ago. Operating income was SEK 107,242,000 against SEK 58,675,000 a year ago. Net income attributable to parent company's shareholders was SEK 80,682,000 or SEK 4.07 per share against SEK 40,918,000 or SEK 2.06 per share a year ago. Return on equity was 28.1% against 14.4% a year ago. Cash flow from operating activities was SEK 107,342,000 against SEK 68,475,000 a year ago. EBITDA was SEK 123 million against SEK 77 million a year ago. Net debt was SEK 0.6 million. For the quarter, the parent company reported operating loss of SEK 1,979,000 against SEK 1,635,000 a year ago. Net loss was SEK 1,487,000 against SEK 330,000 a year ago. For the nine months, the parent company reported operating loss of SEK 3,817,000 against SEK 4,400,000 a year ago. Net loss was SEK 3,759,000 against SEK 2,940,000 a year ago.

Vitrolife AB (publ) - Analyst/Investor Day

To provide update on the operative and financial development of the Vitrolife Group and look deeper into the future of the IVF field; and to discuss the agreement entered to acquire all the shares of Unisense FertiliTech A/S

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VITR:SS kr177.50 SEK -0.50

VITR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bionet Corp 38.70 TWD -0.10
Cryo-Cell International Inc $2.27 USD 0.00
CryoLife Inc $11.76 USD +0.25
Osiris Therapeutics Inc $16.82 USD +0.31
Smith & Nephew PLC 1,201 GBp +1.00
View Industry Companies
 

Industry Analysis

VITR

Industry Average

Valuation VITR Industry Range
Price/Earnings 31.8x
Price/Sales 6.1x
Price/Book 8.0x
Price/Cash Flow 34.8x
TEV/Sales 6.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITROLIFE AB, please visit www.vitrolife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.